MEDANTA - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.6

📉 MEDANTA is currently in a weak technical phase with oversold momentum, but strong fundamentals and volume support make it a cautious intraday candidate.

🔍 Positive

• ROCE (19.6%) and ROE (15.2%) indicate strong operational efficiency.
• EPS of ₹17.9 and consistent PAT growth (₹129 Cr. to ₹137 Cr.) show earnings stability.
• Volume (4.72L) is above 1-week average (3.47L), indicating strong intraday participation.
• DII holding increased by 0.77%, reflecting domestic institutional confidence.
• Debt-to-equity ratio of 0.10 suggests low financial leverage.

⚠️ Limitation

• RSI at 32.3 and MACD at -13.8 indicate oversold and bearish momentum.
• Current price below both 50 DMA (₹1,342) and 200 DMA (₹1,266) implies short-term weakness.
• Dividend yield of 0.04% is negligible for income-focused investors.
• PEG ratio of 2.12 suggests the stock may be overvalued relative to its growth.

📰 Company Negative News

• FII holding declined by 0.13%, signaling reduced foreign investor interest.

📢 Company Positive News

• Quarterly profit variance of 42.2% highlights strong operational performance and margin expansion.

🏭 Industry

• Healthcare and hospital sector benefits from rising demand and long-term structural growth.
• Industry P/E of 57.2 reflects optimism but also valuation caution.

🧾 Conclusion

• MEDANTA offers a cautious intraday setup with strong fundamentals and volume support.
• Best suited for scalping trades near support with tight stop loss and defined exit levels.
• Monitor RSI and MACD for signs of reversal before entering aggressively.

I can track MEDANTA’s RSI and MACD live to notify you when momentum strengthens for a safer entry.